- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT00879944
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Several environmental factors and comorbid conditions have been found to be associated with psoriasis in adults, including obesity, depression, smoking, and other cardiovascular risk factors such as high blood pressure. The object of this research study is to examine these associations in children as very little is known about psoriasis and cardiovascular risk factors in the pediatric population.
This is a multi-center study with a planned total enrollment of about 200 subjects ages 2-17 years old with psoriasis and 100 aged-match controls. Patient and family history will be recorded. All subjects will undergo standard height, weight, blood pressure, and waist circumference (WC). For the obese and overweight subjects we will also obtain their growth charts to attempt to correlate weight gain with psoriasis onset and progression. All data will be compiled and then statistically analyzed.
Tipo de estudo
Inscrição (Real)
Contactos e Locais
Locais de estudo
-
-
Newfoundland and Labrador
-
St. John's, Newfoundland and Labrador, Canadá
- Nexus Clinical Resarch
-
-
-
-
-
Santiago, Chile
- Pontificia Universidad Católica de Chile
-
-
-
-
California
-
San Diego, California, Estados Unidos, 92123
- University of California, San Diego
-
San Francisco, California, Estados Unidos, 94143
- University of California, San Francisco
-
Stanford, California, Estados Unidos, 94305
- Stanford University School of Medicine
-
-
Illinois
-
Chicago, Illinois, Estados Unidos, 60611
- Ann & Robert H Lurie Children's hospital of Chicago
-
-
Massachusetts
-
Worcester, Massachusetts, Estados Unidos, 01605
- UMass Memorial Dermatology Center
-
-
Missouri
-
St. Louis, Missouri, Estados Unidos, 63117-1206
- Central Dermatology
-
-
Ohio
-
Cleveland, Ohio, Estados Unidos, 44106
- University Hospitals, Case Medical Centers
-
-
Texas
-
Dallas, Texas, Estados Unidos, 75246
- Texas Dermatology Associates
-
Houston, Texas, Estados Unidos, 77030
- Texas Children's Hospital
-
-
-
-
-
Nijmegen, Holanda
- UMC St. Radboud
-
-
-
-
-
Tuen Mun, Hong Kong
- University of Hong Kong
-
-
-
-
-
Verona, Itália
- Universita Verona
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
- Children ages 5 to 17 years old with either moderate or severe plaque type psoriasis
- Children ages 5 to 17 years old with moderate or severe atopic dermatitis
- Children ages 5 to 17 years old seen in dermatology clinic who are healthy and without a systemic disorder.
Descrição
Inclusion Criteria:
- Subjects must be between the ages of 5 and 17 years at the time of enrollment.
- Subjects of either sex.
- Subjects who have had psoriatic plaques for more than 6 months.
- Subjects and guardians of minors must sign the approved IRB consent form(s) prior to initiation of the study protocol.
- Subjects enrolled as "non-inflammatory" normal controls will carry a common non- systemic skin condition, such as acne, nevi, warts and molluscum as their main diagnosis.
- Subjects enrolled as "inflammatory" normal controls will carry a diagnosis of moderate to severe atopic dermatitis.
Exclusion Criteria:
- Subjects who are unable to give informed consent or assent.
- Subjects who have had psoriasis for less than 6 months.
- Subjects whose condition is deemed unsafe or incapable by the study investigator for study participation.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
|---|---|
|
Psoriasis
Children ages 5-17 years old with moderate or severe plaque type psoriasis.
Blood pressure will be measured once while patient is seated Height will be measured in centimeters at the time of enrollment Weight will be measured in kilograms at enrollment Body Mass Index (BMI) will be calculated from a subject's height and weight Waist circumference will be measured midway between the lowest rib and the superior border of the iliac crest with an inelastic measuring tape at the end of normal expiration to the nearest 0.1cm
|
Blood pressure will be measured once while patient is seated
Height will be measured in centimeters at the time of enrollment
Weight will be measured in kilograms at enrollment
Body Mass Index (BMI) will be calculated from a subject's height and weight
Waist circumference will be measured midway between the lowest rib and the superior border of the iliac crest with an inelastic measuring tape at the end of normal expiration to the nearest 0.1cm
|
|
Atopic Dermatitis Controls
Children ages 5 to 17 years old with moderate to severe atopic dermatitis.
Blood pressure will be measured once while patient is seated Height will be measured in centimeters at the time of enrollment Weight will be measured in kilograms at enrollment Body Mass Index (BMI) will be calculated from a subject's height and weight Waist circumference will be measured midway between the lowest rib and the superior border of the iliac crest with an inelastic measuring tape at the end of normal expiration to the nearest 0.1cm
|
Blood pressure will be measured once while patient is seated
Height will be measured in centimeters at the time of enrollment
Weight will be measured in kilograms at enrollment
Body Mass Index (BMI) will be calculated from a subject's height and weight
Waist circumference will be measured midway between the lowest rib and the superior border of the iliac crest with an inelastic measuring tape at the end of normal expiration to the nearest 0.1cm
|
|
Healthy Controls
Children 5-17 years of age who are healthy and seen in dermatology clinic for a non-systemic skin condition. Blood pressure will be measured once while patient is seated Height will be measured in centimeters at the time of enrollment Weight will be measured in kilograms at enrollment Body Mass Index (BMI) will be calculated from a subject's height and weight Waist circumference will be measured midway between the lowest rib and the superior border of the iliac crest with an inelastic measuring tape at the end of normal expiration to the nearest 0.1cm |
Blood pressure will be measured once while patient is seated
Height will be measured in centimeters at the time of enrollment
Weight will be measured in kilograms at enrollment
Body Mass Index (BMI) will be calculated from a subject's height and weight
Waist circumference will be measured midway between the lowest rib and the superior border of the iliac crest with an inelastic measuring tape at the end of normal expiration to the nearest 0.1cm
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Prazo |
|---|---|
|
BMI
Prazo: 07/2010
|
07/2010
|
Medidas de resultados secundários
Medida de resultado |
Prazo |
|---|---|
|
Blood Pressure
Prazo: 07/2010
|
07/2010
|
|
Waist circumference
Prazo: 07/2010
|
07/2010
|
Colaboradores e Investigadores
Patrocinador
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Estimativa)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- AP-2009-13793
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .